Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 273.1 USD 2.51%
Market Cap: 19.1B USD
Have any thoughts about
Insulet Corp?
Write Note

Insulet Corp
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Insulet Corp
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Insulet Corp
NASDAQ:PODD
Inventory
$444.9m
CAGR 3-Years
20%
CAGR 5-Years
38%
CAGR 10-Years
47%
Becton Dickinson and Co
NYSE:BDX
Inventory
$3.8B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Inventory
$2.8B
CAGR 3-Years
20%
CAGR 5-Years
12%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Inventory
$5.3B
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
12%
Abbott Laboratories
NYSE:ABT
Inventory
$6.8B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Inventory
$1.5B
CAGR 3-Years
36%
CAGR 5-Years
21%
CAGR 10-Years
22%
No Stocks Found

Insulet Corp
Glance View

Market Cap
19.2B USD
Industry
Health Care

Insulet Corporation is a pioneering medical device company, primarily recognized for its innovative Omnipod Insulin Management System, which revolutionizes diabetes care. Founded in 2000, Insulet has focused on developing patch pump technology that offers a seamless, tubeless insulin delivery solution for individuals with insulin-dependent diabetes. This cutting-edge product allows users to manage their insulin delivery discreetly and conveniently, enhancing their quality of life and simplifying the complex regimen of diabetes management. As the prevalence of diabetes continues to rise globally, Insulet stands at the forefront of meeting a substantial medical need, capturing a significant market share with its user-friendly technology. As an investor, understanding Insulet’s growth trajectory and market potential is essential. The company has witnessed consistent revenue growth, driven by increased adoption of its Omnipod systems, and has expanded its product portfolio to include a new generation of devices that offer even greater functionality. Insulet is also heavily investing in research and development to further innovate its offerings, positioning itself competitively in the fast-evolving diabetes care market. With strong industry partnerships and a commitment to enhancing user experience, Insulet represents not just a promising investment in healthcare technology but also a company that is fundamentally improving the lives of millions.

PODD Intrinsic Value
99.02 USD
Overvaluation 64%
Intrinsic Value
Price

See Also

What is Insulet Corp's Inventory?
Inventory
444.9m USD

Based on the financial report for Sep 30, 2024, Insulet Corp's Inventory amounts to 444.9m USD.

What is Insulet Corp's Inventory growth rate?
Inventory CAGR 10Y
47%

Over the last year, the Inventory growth was 8%. The average annual Inventory growth rates for Insulet Corp have been 20% over the past three years , 38% over the past five years , and 47% over the past ten years .

Back to Top